Orbital implant receives innovation award

Article

The new AlphaSphere Orbital Implant ophthalmic device has been awarded the 2010 Alpha Award for Innovation In Engineering & Technology presented by the Engineering Society of Detroit.

The new AlphaSphere Orbital Implant ophthalmic device has been awarded the 2010 Alpha Award for Innovation In Engineering & Technology presented by the Engineering Society of Detroit.

Art Brodie, Executive Vice President, Business Development at Addition Technology, the maker of the product said: “We view the engineering, materials and design of the AlphaSphere device to be a quantum leap forward in orbital implant technology. Although AlphaSphere was only launched in the second half of 2009, we have already seen surgeons at Bascom Palmer, Yale and Mass. Eye & Ear to name a few begin to use the device, and though the results are short-term, the light-weight, smooth and bio-integratable characteristics have generated very favourable feedback.”

The implant is a new entry into an historical market that dates back to 1884. It is the first orbital implant device made from a novel poly-HEMA bio-material (PHEMA) that biointegrates into the eye socket capsule yet resists bio-integration in its posterior hemisphere to provide S motility to a prosthetic eye. Since the majority of its composition is water, AlphaSphere’s ability to provide compliance in matching natural organ tissue is claimed by its makers to be unique in comparison to other orbital implant products due to its soft, smooth and pliable exterior. A major feature is the ability to directly suture into the endo-skeletal, anterior surface.

www.AdditionTechnology.com will give you more information.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.